The effect of chemotherapy on the tumor immune microenvironment in non-small cell lung cancer (NSCLC): A single-institution retrospective analysis.

被引:1
|
作者
Devitt, Michael Edward
Gade, Kristine E.
Hall, Richard Delmar
Horton, Bethany J.
Stelow, Edward B.
Bullock, Timothy
Gentzler, Ryan D.
机构
[1] Univ Virginia, Charlottesville, VA USA
[2] Univ Virginia Hlth Syst, Charlottesville, VA USA
[3] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
关键词
D O I
10.1200/JCO.2018.36.5_suppl.155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
155
引用
收藏
页数:2
相关论文
共 50 条
  • [1] RETROSPECTIVE ANALYSIS OF NON-SMALL CELL LUNG CANCER (NSCLC) SURGICAL MANAGEMENT IN A SINGLE INSTITUTION STUDY.
    Bowers, P. J. B.
    Dhital, K.
    Granger, E.
    Jansz, P.
    Spratt, P.
    Stone, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S160 - S160
  • [2] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [3] Neoadjuvant chemotherapy in non small cell lung cancer (NSCLC): A retrospective evaluation of a single institution experience
    Martin, C
    Oconors, J
    Coronado, C
    Toosen, G
    Van Kooten, M
    Chacon, M
    Rosemberg, C
    Chacon, R
    [J]. LUNG CANCER, 2005, 49 : S381 - S381
  • [4] Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC)
    Zhang, F.
    Dong, N.
    Torres, S.
    Calabuig Farinas, S.
    Sirera Perez, R.
    Mosqueda, M.
    Escorihuela, E.
    Jantus-Lewintre, E.
    Camps, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review
    Enting, D.
    Januszewski, A.
    Benepal, T.
    [J]. LUNG CANCER, 2012, 75 : S5 - S5
  • [6] Biomarkers in immune microenvironment for predicting the efficacy of immunotherapy with or without chemotherapy in non-small cell lung cancer (NSCLC)
    Deng, R.
    Li, X.
    Xi, W.
    Deng, W.
    Ma, X.
    Ni, Y.
    Song, C.
    Tian, M.
    Wu, H.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S405 - S405
  • [7] Characterization of cancer stem cell and immune microenvironment interactions in non-small cell lung cancer (NSCLC)
    Torres, S.
    Sirera, R.
    Aguilar, C.
    Calabuig Farinas, S.
    Mosqueda, M.
    Herreros-Pomares, A.
    Escorihuela, E.
    Garcia del Olmo, E.
    Jantus-Lewintre, E.
    Camps Herrero, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] Tumor microenvironment (TME) of HRAS mutated non-small cell lung cancer (NSCLC)
    Trabolsi, A.
    Rodriguez, E.
    Kareff, S.
    Gallegos, J. A. Ocejo
    Yin, J.
    Walker, P.
    Mamdani, H.
    Nieva, J. J.
    Borghaei, H.
    Nabhan, C.
    Nagasaka, M.
    Puri, S.
    Liu, S. V.
    Halmos, B.
    Lopes, G.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1041 - S1041
  • [9] Radiation and Modulation of the Tumor Immune Microenvironment in Non-Small Cell Lung Cancer
    Goff, Peter H.
    Zeng, Jing
    Rengan, Ramesh
    Schaub, Stephanie K.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (02) : 133 - 139
  • [10] Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study
    Freile, Berenice
    Enrico, Diego
    Tsou, Florencia
    Waisberg, Federico
    Rodriguez, Andres
    Pombo, Teresa
    Mendoza, Andrea
    Salanova, Ruben
    Chacon, Matias
    Pupareli, Carmen Sofia
    Martin, Claudio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S10 - S11